Table 1.
Clinical, biochemical, and Anthropometric characteristics of the enrolled population (n = 285). Continuous variables are reported by median and interquartile ranges (IQR). Patients are stratified by presence (n = 114) and absence (n = 171) of NAFLD.
| Variable (Normal Values) | All Patients (n = 285) |
Group A (NAFLD), (n = 114) |
Group B (without NAFLD), (n = 171) |
Significance |
|---|---|---|---|---|
| Age, years | 76 (75; 76) | 76 (75; 76) | 76 (75; 77) | NS |
| Educational level, years | 11 (10; 12) | 9 (8; 12) | 12 (11; 12) | p < 0.001 |
| Gender M, n % | 148 (51.9%) | 59 (51.7%) | 89 (52%) | NS |
| HbA1C, % | 5.9 (5.7; 6.5) | 6.7 (6.3; 6.9) | 5.7 (5.4; 5.9) | p < 0.001 |
| LDL, mg/dL | 122.7 (112.3; 132.4) | 132.9 (5.1) | 112.4 (109.8; 121.4) | p < 0.001 |
| Vitamin DOH25, mg/dL | 12.3 (9.5; 17.8) | 9.4 (9.2; 9.7) | 16.5 (12.5; 17.9) | p < 0.001 |
| Folate, ng/mL | 2.5 (2.3; 3.8) | 2.3 (2.1; 2.4) | 3.1 (2.5; 4.2) | p < 0.001 |
| Vitamin B12, pg/mL | 145.4 (129.4; 154.3) | 123.4 (122.4; 132.4) | 154.3 (145.4; 157.6) | p < 0.001 |
| homocysteine, µmol/L | 19.2 (15.3; 23.4) | 23.4 (22.3; 24.1) | 15.4 (14.1; 18.95) | p < 0.001 |
| ALT (IU/L) | 33 (29; 43) | 44 (43; 45) | 29.8 (28.75; 32.2) | p < 0.001 |
| AST (IU/L) | 34 (32; 43) | 44 (43; 46) | 33.1 (29.4; 34.3) | p < 0.001 |
| BMI | 24 (23; 34) | 34 (34; 35) | 23 (22; 24) | p < 0.001 |
Abbr. HbA1C—glycate hemoglobin; LDL—low-density lipoprotein; ALT—alanine aminotransferase; AST—aspartate aminotransferase; BMI—body mass index.